vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Morningstar, Inc. (MORN). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $644.8M, roughly 1.6× Morningstar, Inc.). On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 10.8%). Morningstar, Inc. produced more free cash flow last quarter ($53.6M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 6.2%).

Morningstar, Inc. is an American financial services firm headquartered in Chicago, Illinois, founded by Joe Mansueto in 1984. It provides an array of investment research and investment management services.

ECG vs MORN — Head-to-Head

Bigger by revenue
ECG
ECG
1.6× larger
ECG
$1.0B
$644.8M
MORN
Growing faster (revenue YoY)
ECG
ECG
+22.3% gap
ECG
33.2%
10.8%
MORN
More free cash flow
MORN
MORN
$30.1M more FCF
MORN
$53.6M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
6.2%
MORN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ECG
ECG
MORN
MORN
Revenue
$1.0B
$644.8M
Net Profit
$55.3M
Gross Margin
11.6%
62.9%
Operating Margin
6.8%
24.2%
Net Margin
5.5%
Revenue YoY
33.2%
10.8%
Net Profit YoY
60.4%
EPS (diluted)
$1.09
$2.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
MORN
MORN
Q1 26
$644.8M
Q4 25
$1.0B
$641.1M
Q3 25
$986.8M
$617.4M
Q2 25
$921.5M
$605.1M
Q1 25
$826.6M
$581.9M
Q4 24
$759.6M
$591.0M
Q3 24
$761.0M
$569.4M
Q2 24
$703.4M
$571.9M
Net Profit
ECG
ECG
MORN
MORN
Q1 26
Q4 25
$55.3M
$115.1M
Q3 25
$57.0M
$91.6M
Q2 25
$52.8M
$89.0M
Q1 25
$36.7M
$78.5M
Q4 24
$34.5M
$116.9M
Q3 24
$41.8M
$119.7M
Q2 24
$39.0M
$69.1M
Gross Margin
ECG
ECG
MORN
MORN
Q1 26
62.9%
Q4 25
11.6%
61.1%
Q3 25
12.6%
60.9%
Q2 25
13.0%
61.9%
Q1 25
11.2%
60.2%
Q4 24
11.4%
60.7%
Q3 24
11.8%
60.9%
Q2 24
12.6%
61.1%
Operating Margin
ECG
ECG
MORN
MORN
Q1 26
24.2%
Q4 25
6.8%
24.9%
Q3 25
7.3%
20.7%
Q2 25
7.9%
20.7%
Q1 25
6.2%
19.6%
Q4 24
6.1%
28.5%
Q3 24
7.1%
20.3%
Q2 24
7.3%
19.0%
Net Margin
ECG
ECG
MORN
MORN
Q1 26
Q4 25
5.5%
18.0%
Q3 25
5.8%
14.8%
Q2 25
5.7%
14.7%
Q1 25
4.4%
13.5%
Q4 24
4.5%
19.8%
Q3 24
5.5%
21.0%
Q2 24
5.5%
12.1%
EPS (diluted)
ECG
ECG
MORN
MORN
Q1 26
$2.73
Q4 25
$1.09
$2.79
Q3 25
$1.11
$2.17
Q2 25
$1.03
$2.09
Q1 25
$0.72
$1.82
Q4 24
$0.68
$2.72
Q3 24
$0.82
$2.77
Q2 24
$0.76
$1.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
MORN
MORN
Cash + ST InvestmentsLiquidity on hand
$492.8M
Total DebtLower is stronger
$281.5M
$1.7B
Stockholders' EquityBook value
$629.8M
$1.0B
Total Assets
$1.7B
$4.0B
Debt / EquityLower = less leverage
0.45×
1.68×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
MORN
MORN
Q1 26
$492.8M
Q4 25
$528.7M
Q3 25
$40.3M
Q2 25
$38.1M
Q1 25
$47.7M
Q4 24
$551.0M
Q3 24
$553.0K
$48.8M
Q2 24
$48.0M
Total Debt
ECG
ECG
MORN
MORN
Q1 26
$1.7B
Q4 25
$281.5M
Q3 25
$285.1M
$848.9M
Q2 25
$288.6M
$838.8M
Q1 25
$292.1M
$803.7M
Q4 24
$295.6M
$698.6M
Q3 24
$864.7M
Q2 24
$899.6M
Stockholders' Equity
ECG
ECG
MORN
MORN
Q1 26
$1.0B
Q4 25
$629.8M
$1.2B
Q3 25
$573.0M
$1.5B
Q2 25
$514.4M
$1.6B
Q1 25
$460.2M
$1.6B
Q4 24
$422.6M
$1.6B
Q3 24
$453.3M
$1.6B
Q2 24
$490.0M
$1.4B
Total Assets
ECG
ECG
MORN
MORN
Q1 26
$4.0B
Q4 25
$1.7B
$3.6B
Q3 25
$1.6B
$3.6B
Q2 25
$1.5B
$3.6B
Q1 25
$1.4B
$3.6B
Q4 24
$1.3B
$3.5B
Q3 24
$1.3B
$3.6B
Q2 24
$3.4B
Debt / Equity
ECG
ECG
MORN
MORN
Q1 26
1.68×
Q4 25
0.45×
Q3 25
0.50×
0.56×
Q2 25
0.56×
0.52×
Q1 25
0.63×
0.50×
Q4 24
0.70×
0.43×
Q3 24
0.55×
Q2 24
0.63×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
MORN
MORN
Operating Cash FlowLast quarter
$48.2M
Free Cash FlowOCF − Capex
$23.5M
$53.6M
FCF MarginFCF / Revenue
2.3%
8.3%
Capex IntensityCapex / Revenue
2.4%
5.9%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$437.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
MORN
MORN
Q1 26
Q4 25
$48.2M
$204.0M
Q3 25
$76.2M
$195.7M
Q2 25
$25.3M
$99.0M
Q1 25
$7.1M
$91.0M
Q4 24
$153.4M
Q3 24
$78.9M
$191.9M
Q2 24
$152.7M
Free Cash Flow
ECG
ECG
MORN
MORN
Q1 26
$53.6M
Q4 25
$23.5M
$161.3M
Q3 25
$65.7M
$160.1M
Q2 25
$12.3M
$62.4M
Q1 25
$-11.4M
$58.8M
Q4 24
$112.8M
Q3 24
$60.9M
$155.8M
Q2 24
$120.8M
FCF Margin
ECG
ECG
MORN
MORN
Q1 26
8.3%
Q4 25
2.3%
25.2%
Q3 25
6.7%
25.9%
Q2 25
1.3%
10.3%
Q1 25
-1.4%
10.1%
Q4 24
19.1%
Q3 24
8.0%
27.4%
Q2 24
21.1%
Capex Intensity
ECG
ECG
MORN
MORN
Q1 26
5.9%
Q4 25
2.4%
6.7%
Q3 25
1.1%
5.8%
Q2 25
1.4%
6.0%
Q1 25
2.2%
5.5%
Q4 24
6.9%
Q3 24
2.4%
6.3%
Q2 24
5.6%
Cash Conversion
ECG
ECG
MORN
MORN
Q1 26
Q4 25
0.87×
1.77×
Q3 25
1.34×
2.14×
Q2 25
0.48×
1.11×
Q1 25
0.19×
1.16×
Q4 24
1.31×
Q3 24
1.89×
1.60×
Q2 24
2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

MORN
MORN

Segment breakdown not available.

Related Comparisons